Amplification and detection of ribonucleic acids

US9416406B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9416406-B2
Application numberUS-201414571142-A
CountryUS
Kind codeB2
Filing dateDec 15, 2014
Priority dateJan 14, 2008
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions, methods, and kits for detecting one or more species of RNA molecules are disclosed. In one embodiment, a first adaptor and a second adaptor are ligated to the RNA molecule using a polypeptide comprising double-strand specific RNA ligase activity, without an intervening purification step. The ligated product is reverse transcribed, then at least some of the ribonucleosides in the reverse transcription product are removed. Primers are added and amplified products are generated. In certain embodiments, the sequence of at least part of at least one species of amplified product is determined and at least part of the corresponding RNA molecule is determined. In some embodiments, at least some of the amplified product species are detected, directly or indirectly, allowing the presence and/or quantity of the RNA molecule of interest to be determined.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for detecting an RNA molecule, comprising: (a) forming a single ligation reaction mixture containing (i) at least one RNA molecule including at least a first and a second RNA molecule, (ii) a plurality of a first double-stranded nucleic acid adaptor, (iii) a plurality of a second double-stranded nucleic acid adaptor, and (iv) an RNA ligase, wherein a first strand of the first double-stranded nucleic acid adaptors of the plurality include at least two ribonucleosides at the 3′ end, and a second strand of the first double-stranded nucleic acid adaptors of the plurality include a first single-stranded portion at the 5′ end, and wherein a first strand of the second double-stranded nucleic acid adaptors of the plurality include a terminal 5′ phosphate group, and a second strand of the second double-stranded nucleic acid adaptors of the plurality include a second single-stranded portion at the 3′ end, and wherein the first and the second single-stranded portions contain a nucleotide sequence that hybridizes to a portion of the at least first RNA molecule from the mixture of different RNA molecules, and wherein the first double-stranded adaptors of the plurality, or the second double-stranded adaptors of the plurality, or the first and second double-stranded adaptors comprise a unique bar code sequence; and (b) producing a plurality of different RNA ligation product by ligating the first double-stranded adaptor to a first end of the at least one RNA molecule and ligating the second double-stranded adaptor to a second end of the at least one RNA molecule. 2. The method of claim 1 further comprising: (a) producing a first strand cDNA product by reverse transcribing the at least one RNA ligation product; (b) producing a plurality of amplification products by amplifying the first strand cDNA product; and (c) detecting at least one amplification product. 3. The method of claim 1 , wherein the RNA ligase comprises an Rnl2 family ligase. 4. The method of claim 3 , wherein the RNA ligase comprises bacteriophage T4 RNA ligase 2 (Rnl2). 5. The method of claim 1 , wherein the first single-stranded portion of the first double-stranded adaptors of the plurality and the second single-stranded portion of the second double-stranded adaptors of the plurality, comprise degenerate sequences. 6. The method of claim 1 , wherein the amplifying in step (b) comprises PCR amplifying with at least one forward amplification primer and at least one reverse amplification primer. 7. The method of claim 6 , wherein the at least one forward amplification primer or the at least one reverse amplification primer includes a unique identification sequence. 8. The method of claim 1 , wherein the RNA molecule is a small non-coding RNA or an RNA fragment. 9. The method of claim 1 , wherein the first strand of the first double-stranded adaptor and the first strand of the second double-stranded adaptor comprise different nucleotide sequences. 10. The method of claim 1 , wherein the first single-stranded portions of the plurality of first double-stranded nucleic acid adaptors contain different sequences, and wherein the second single-stranded portions of the plurality of second double-stranded nucleic acid adaptors contain different sequences. 11. The method of claim 2 , wherein the detecting comprises sequencing the plurality of amplification product. 12. The method of claim 1 , wherein the first single-stranded portion or the second single-stranded portion, or the first single-stranded portion and the second single-stranded portion comprise a sequence-specific region to selectively hybridize with the portion of the RNA molecule. 13. The method of claim 1 , wherein first single-stranded portion of the first double-stranded adaptors of the plurality and the second single-stranded portion of the second double-stranded adaptors of the plurality, comprises adenosine, guanosine, cytidine, and thymidine. 14. The method of claim 2 , wherein the reverse transcribing of step (a) comprises contacting the at least one RNA ligation product with triphosphate nucleotides, and (i) an RNA-dependent DNA polymerase, (ii) a DNA polymerase having DNA-dependent DNA polymerase activity and RNA-dependent DNA polymerase activity, or (iii) an RNA-dependent DNA polymerase and a DNA-dependent DNA polymerase. 15. The method of claim 2 , wherein the amplifying in step (b) comprises contacting the first strand cDNA product with triphosphate nucleotides, at least one forward amplification primer, at least one reverse amplification primer and a DNA-dependent DNA polymerase. 16. The method of claim 1 , wherein at least one of the at least one first double-stranded adaptor or at least one second double-stranded adaptor comprises an identification sequence.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9416406B2 cover?
Compositions, methods, and kits for detecting one or more species of RNA molecules are disclosed. In one embodiment, a first adaptor and a second adaptor are ligated to the RNA molecule using a polypeptide comprising double-strand specific RNA ligase activity, without an intervening purification step. The ligated product is reverse transcribed, then at least some of the ribonucleosides in the r…
Who is the assignee on this patent?
Applied Biosystem Llc, Applied Biosystems Llc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6855. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).